Cenra Inc. (TPE:3716)
Taiwan · Delayed Price · Currency is TWD 33.90
+0.10 (0.30%)
At close: Feb 11, 2026
Cenra Market Cap
Cenra has a market cap or net worth of 4.96 billion as of February 13, 2026. Its market cap has decreased by -9.99% in one year.
Market Cap
4.96B
Enterprise Value
7.34B
Revenue
8.68B
Ranking
n/a
PE Ratio
12.78
Stock Price
33.90
Market Cap Chart
Since September 2, 2024, Cenra's market cap has decreased from 6.21B to 4.96B, a decrease of -20.13%. That is a compound annual growth rate of -14.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 4.96B | 1.50% |
| Dec 31, 2025 | 4.88B | -12.15% |
| Dec 31, 2024 | 5.56B | -10.42% |
| Sep 2, 2024 | 6.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 268.14B |
| Caliway Biopharmaceuticals | 248.00B |
| Lotus Pharmaceutical | 76.92B |
| Heron Neutron Medical | 74.10B |
| Panion & Bf Biotech | 5.28B |
| UnicoCell Biomed | 5.28B |
| Steminent Biotherapeutics | 5.17B |
| SciVision Biotech | 5.17B |